a wholly owned subsidiary of La Jolla Pharmaceutical Company

A CRITICAL MISSION TO SAVE MILLIONS AT RISK

Tetraphase is fighting one of the most significant threats to humanity — antibiotic resistance — through the promise of our technology and the passion of our people. We are committed to making novel antibiotics accessible to all patients in need.

Learn More

Novel Technology has Delivered Promising Products

Our proprietary chemistry technology is yielding multiple tetracycline-based antibiotics with activity against some of the most challenging multidrug-resistant bacteria.

SEE OUR SCIENCE

Pipeline Products Available for Out-Licensing

Our products in development have the potential to change the course of antibiotic resistance for millions of patients at risk.

PIPELINE

To:

Please enter a valid email address.

From:

Please enter a valid email address.

Share information about Tetraphase

Cancel

Thank you!
Your email has been sent.

Thank you for your request.

Someone will contact you shortly.

OK